A Nevada Mother Warned Everyone About Invega Withdrawal. No One Stopped What Came Next.

ELKO, Nev. — Oct. 23, 2026 (The Oklahoma Post)
Content warning: This story describes domestic violence, serious injury, homicide, self-harm, psychosis, drug use and suicide risk. If you or someone you know is in crisis, call or text 988, the Suicide and Crisis Lifeline.

The baby’s eyelids had barely settled into sleep.

Carina Pedersen still clings to that final fragment of peace: her five-month-old son, smiling up at her in the shadowed bedroom on the night of Aug11, before his eyes softly drifted shut. She had locked the door behind them, a desperate nightly ritual born of pure necessity. Because of Invega withdrawal, her husband no longer knew day from night, swallowed whole by the twisting corridors of delusion and paranoia.

The Last Moment of Peace

Sometimes he would knock in the dead of night, at 3 a.m., his mind chasing a ghost of a question.

This time, there was no knock.

“The instant I see my baby’s eyes closed,” she remembered, “there is an impending doom thud on my door.”

Then came the terror in rapid, frantic cadence: the violent slap of footsteps sprinting down the hardwood hall, the heavy clash of metal echoing from the garage, and the sound of him charging back. When the door gave way, David Pedersen, a giant of a man she once knew only as a gentle, tender “teddy bear”, stood framed in the entryway, a hammer gripped in his right hand.

The cold steel, heavy and worn, bit into her again and again a brutal cadence she couldn’t keep count of, though Sheriff Aitor Narvaiza’s office would later call it “multiple.” Bloodied and breaking, she lifted a trembling hand toward heaven, her voice rising in a desperate plea for God to spare her and her son.

She lived. She is permanently blind in one eye. He is charged with attempted murder. He has not been convicted.

And she does not blame him.

“I would never prosecute my husband,” she said. “He’s a victim too.”

She blames a drug made by Johnson & Johnson, the label that came with it and the Elko County Sheriff’s Office. For months before that night, she says, she warned every authority she could reach that her husband was coming off Invega Sustenna and losing his grip on reality. She carried a psychiatrist’s letter calling him a danger to himself and others. She went to the sheriff himself.

Every door, she says, closed.

This is the Story of Those Doors

It rests on two long interviews with Carina Pedersen, letters and records she provided, the drug’s federal label, published research and the sheriff’s office’s own statements. The shape of the failure is already visible. Three systems were supposed to protect this family: the drug’s maker and the federal regulators who approve its label, the doctors who managed his medication, and the police with the legal power to take a man in crisis to a hospital just nine miles away.

Not one of them did.

The Wife, The Servant, The Leader, A Preventable Nightmare

Carina Pedersen is 33. In 2020, at the bottom of her life, she lost the dog that she says had saved her. She turned to God and “knew there was no going back.”

She met David Pedersen, 39, on a Christian bible study zoom meeting. They married July, 2025, and bought a 10-acre ranch, outside Elko, with an old saloon on the property where David planned a men’s breakfast ministry.

David wrote Christian music. He was a Star Wars fan, a former college football player, “a nerd, big teddy bear sweetheart.” Before they moved in, she said, he found a neighbor drunk with a gun, talking about killing himself, and stayed with him all night, then checked on him for a week. Growing into a role as a servant and a leader. A dad. A member of the local church. That is David.

David’s testimony began years ago, she said. He became a new man and used his story to bring others to God.

About 15 years ago he caused a crash that killed two people and went to prison, where she says inmates stabbed him and he spent months in isolation. He came out damaged, she said, shocked at what had come of his life, a stranger to himself. Then he turned to Jesus Christ. He became a Christian and spoke to high school students about living a fulfilling life.

When Carina met David, he was taking prescribed Adderall and kratom, an herbal supplement, for his injuries. He finished a treatment program to come off both in December 2024.

And he was taking Invega.

Then, she says, the pendulum swung, because of a prescribed drug.


The Market for Invega

Invega is Johnson & Johnson’s brand of paliperidone, an antipsychotic made by its Janssen unit. It comes as a daily pill and as Invega Sustenna, a monthly injection approved for schizophrenia. Antipsychotics are powerful drugs. They quiet psychosis by blocking dopamine receptors in the brain, and for many patients they are lifesaving.

J&J knows the power of the market for them. In 2013 it agreed to pay more than $2.2 billion to resolve criminal and civil allegations that it promoted Risperdal and Invega for uses the FDA never approved and paid kickbacks to doctors and pharmacies. Janssen pleaded guilty to a misdemeanor. J&J denied the civil allegations. That case was about marketing, not violence. It is a reminder of how much the company has had riding on these drugs.

Five years later, J&J found a new market for Invega Sustenna: the criminal justice system.

In January 2018 the FDA approved adding data from a Janssen-funded study, known as PRIDE, to the Invega Sustenna label. The company’s press release called it “landmark schizophrenia data that brings hope in breaking the cycle of hospitalization and incarceration.” The study followed 444 adults with schizophrenia, each taken into custody at least twice in the previous two years. Those on the monthly shot went a median of 416 days before “treatment failure” a category that counted arrest and incarceration alongside hospitalization and suicide compared with 226 days for those on daily pills. It did not compare the shot with other long-acting injections.

The Marshall Project put it plainly in its headline: “A Drug Company Says This Shot Will Keep You Out of Prison.” The FDA’s decision came with three more years of market exclusivity, holding off generic competition, the publication reported. Invega Sustenna and its sister drug, Invega Trinza, brought J&J $2.2 billion in 2016. “Depressing commentary” on American mental health care, John Snook, then executive director of the Treatment Advocacy Center, called the jail-avoidance pitch, though he said the drugs can help patients who need them.

The Oklahoma Post has reported on how that pitch reached county jails and courtrooms, including free-sample and jail-injection programs in Maricopa County, Arizona, and Cleveland County, Oklahoma.

David’s psychiatrist, started him on risperidone, an older drug in the same family, and moved him to Invega, his wife said. He climbed to 12 mg a day, the maximum. He tried one or two Sustenna injections, but they were too expensive, so he stayed on the pills.

Carina disputes that her husband ever had schizophrenia. Brain scans from the Amen Clinics, she said, showed damage from trauma and recommended supplements and a sober life. “Psychosis symptoms are not schizophrenia,” she said.

On the drug, she said, he gained weight and lost the quickness he prized. “I used to be so sharp,” he told her, then came the convulsions: his eyes rolling back in his head, movements he could not control. That, she said, is why he asked to come down.

His doctor then wrote the lower prescriptions.

Overlapping Shadows: Schizophrenia vs. Drug Psychosis

Carina Pedersen believes her husband never had schizophrenia. The editor of this newspaper believes the same of his son. Both men had used drugs before a psychotic break. Both were put on Invega. The research on that sequence cuts in two directions, and both matter.

All kinds of things and temporary situations can produce a psychosis that, while it lasts, looks almost exactly like paranoid schizophrenia: persecutory delusions, hallucinations, agitation.

A 2018 review in Frontiers in Psychiatry found “considerable overlap” between the two, though hallucinations of sight and touch were more common with methamphetamine. Most such episodes fade within about a month of stopping the drug, according to published reviews. An estimated 10% to 28% persist beyond six months. Psychiatry’s diagnostic manual treats symptoms that last well past intoxication and withdrawal as a sign of an independent disorder.

Most people whose psychosis is triggered by drugs do not go on to develop schizophrenia. A 2020 meta-analysis in Schizophrenia Bulletin, covering 34,244 people, found that 25% of those treated for substance-induced psychosis were later diagnosed with schizophrenia. After amphetamine-type drugs, including methamphetamine, the rate was 22%. A Finnish registry put the eight-year risk after amphetamine psychosis at 30%, and after opioid-induced psychosis at 21%. In Denmark, a national study of 6,788 patients found 32% went on to a diagnosis of schizophrenia or bipolar disorder within 20 years.

Read one way, those numbers mean three of every four people with a drug-induced psychosis do not have schizophrenia. Read the other way, they mean one in four or five does. Swedish researchers led by Kenneth Kendler found that those who progress carry the same family history of psychosis as other schizophrenia patients evidence that for some, the drug unmasked an illness rather than created one.

Diagnosis is fallible. When Johns Hopkins researchers reviewed 54 patients referred to their early-psychosis clinic with a schizophrenia-spectrum diagnosis, they confirmed it in only 26. Most of the rest had anxiety or mood disorders. “Hearing voices on its own doesn’t mean a diagnosis of schizophrenia,” said Dr. Russell Margolis, clinical director of the Johns Hopkins Schizophrenia Center, who blamed “checklist psychiatry.” The study was small, and its patients had been sent there because their diagnoses were already in doubt. Many had not been asked about their current recreational drug use that could result in temporary hallucinations or psychosis.

David Pedersen’s history carries other weights the research has not resolved: months in isolation in prison, the blows of a football career, a years of kratom and pain medication. A 2011 meta-analysis in Schizophrenia Bulletin found an association between traumatic brain injury and schizophrenia.

And the cost of guessing wrong runs both ways. In Finland, a 20-year study of 8,719 first-episode schizophrenia patients found death rates 174% to 214% higher among those who never took or quickly stopped antipsychotics. Treat a drug psychosis as lifelong schizophrenia, and a young man may spend years on a drug he never needed. Treat real schizophrenia as a passing drug reaction, and he may go without one he needed.

Either way, someone has to watch. The Danish researchers concluded that every patient with a substance-induced psychosis should be offered follow-up. In both of these families, the drug came first and the watching never did.

The Pill That Cannot Be Split

Here is the first door, and it was locked before anyone touched it.

The Invega label tells doctors how to start the drug. It does not tell anyone how to stop.

Invega tablets come in four strengths. The smallest is 1.5 mg. Each tablet “must be swallowed whole,” the label says, and “should not be chewed, divided, or crushed,” according to the FDA-approved prescribing information. The label offers no schedule for coming off. It offers no warning of what can happen when the drug stops. The word “withdrawal” appears in it only in reference to newborns exposed in the womb. Nor was the drug ever tested for dependence. “Paliperidone has not been systematically studied in animals or humans for its potential for tolerance or physical dependence,” the Invega Sustenna label says.

Read those facts together and a trap appears. A patient who tapers down to 1.5 mg has reached the floor. There is no smaller Invega pill. The one he has cannot be split. You must wait for a special liquid version. The only other way off is to stop.

Researchers have spent years warning that the last step is the dangerous one. In a 2021 paper in Schizophrenia Bulletin, a team led by Mark Horowitz and Robin Murray of King’s College London reported that the relationship between an antipsychotic’s dose and its grip on the brain’s D2 receptors is hyperbolic. The final milligrams do far more work than their size suggests. A cut that looks gentle on paper can collapse the blockade all at once.

The authors proposed cutting by ever-smaller amounts, months apart, with final doses as small as one-fortieth of a therapeutic dose. They wrote that the brain’s adaptations to the drug, including heightened dopamine sensitivity, may outlast it. And rapid reductions, psychiatrist James Phelps wrote in a review of the paper, can produce withdrawal effects, hallucinations, delusions, agitation, that look exactly like an illness coming back to a place it never truly existed.

One-fortieth of a therapeutic dose. Invega’s smallest pill is 1.5 mg, and it cannot be cut.

What Stopping Does to the Brain

Psychiatrists agree that people who stop antipsychotic drugs are more likely to become psychotic. They disagree, sharply, about why.

The most rigorous test of slow, supported dose reduction is a British trial of 253 patients, published in The Lancet Psychiatry in 2023. Led by University College London psychiatrist Joanna Moncrieff, a longtime critic of long-term antipsychotic use, the RADAR trial found that 25% of patients assigned to cut their medication were hospitalized with a severe relapse within two years, compared with 13% of those who stayed on their dose. Even gradual, supervised reduction roughly doubled the risk. The patients who cut their doses gained nothing measurable in daily functioning. Moncrieff said she was disappointed.

Some researchers argue that part of that risk is manufactured by the drug itself. Long-term blockade of dopamine receptors, the theory goes, teaches the brain to compensate, and when the drug is pulled away the brain is flooded. “The process of stopping antipsychotics may be causally related to relapse,” Horowitz, Murray and their colleagues wrote in their 2021 paper, “potentially linked to neuroadaptations that persist after cessation, including dopaminergic hypersensitivity.” Their schedule, smaller and smaller cuts, three to six months apart, over “months or years”, has never been tested in a trial.

Others dispute that withdrawal explains much. A 2024 analysis of 1,388 patients from five randomized trials found that relapse after an abrupt stop was not concentrated in the first weeks, as a withdrawal effect would predict. An older review, published in 1997 in Archives of General Psychiatry by Adele Viguera and colleagues, found the opposite: early relapse was higher after abrupt withdrawal than after gradual withdrawal. After an abrupt stop, half of patients had relapsed within 30 weeks.

The non-psychotic effects of stopping are better documented. A 2022 analysis in The Lancet Psychiatry by Lasse Brandt and colleagues, pooling individual patient data, found that within four weeks of stopping, patients had about twice the odds of psychiatric symptoms and more than three times the odds of anxiety, compared with those who stayed on the drug. The analysis does not say how broadly it defined anxiety. Those patients had been taking antipsychotics for only about three weeks. No one has run that study on people who took the drugs for years.

Nor has anyone run it on paliperidone. No study specific to stopping Invega could be found. No study measures what a split tablet delivers; Johnson & Johnson’s medical information service says it found no published research on chewing, splitting or crushing the pills. When David Pedersen cut his 1.5 mg tablet in half on April 11, he took a step no one had studied, in the range where, by Horowitz’s model, each milligram matters most.

Those studies count relapses. They do not describe what rebound, tapering, a switch to another drug, withdrawal-induced psychosis or a clash with over-the-counter products looks like from inside a house. The families in this story do. Invega was built to be taken indefinitely, whatever the patient, the family or the public wants. Its label tells doctors how to start it and nothing about how to stop. The accounts of these families, and of others now coming forward, suggest the drug can create psychiatric harm where none existed and deepen it where it did. If regulators and the medical community examined those facts honestly, they would have to investigate whether Invega meets the legal definition of a dangerous drug.

His wife and other medical professionals believe that coming off the drug, and the medical emergency that followed, caused what she saw next. David Pedersen saw demons in the air and ran from the house slashing at them. He saw strangers in the attic and the garage and called deputies to find them. He believed his relatives were poisoning him with a rag, then that his wife was poisoning his food and water. He told deputies his wife was someone else, a girl named Emily, a witch. He began calling himself God, and Yeshua, and painted his own blood on a door as “the blood of the lamb.” On the last day, he told his wife someone was changing the words in his Bible and asked whether she could see the people standing in the room.

Similarly, in the national story of Peyton Moyer, he called his father to say he had just watched him die in a plane crash. He asked whether his grandmother was alive, because he had seen her death on television. He cut himself and left blood on everything.

Neither family describes a man who was naturally angry. Both describe a man who was terrified; of poison, of demons, of the people closest to him, who had become, in his mind, someone else. Turning on the nearest people is common in paranoid psychosis, and Carina Pedersen calls it “textbook”: the fear started with his relatives, she said, and moved to her “because I was the only one around.”

Two more facts frame the debate. Being on an antipsychotic is associated with less violence: a 2014 Swedish study of 82,647 patients in The Lancet found violent crime fell 45% during the periods people took them. And no study has separated violence caused by withdrawal from violence caused by an illness returning. That gap is the whole argument, and it is where families like the Pedersens and Moyers live.

A figure circulating among advocates that about 70% of 585 people who tried to quit antipsychotics suffered severe psychosis, but this misstates the study it comes from. That 2022 online survey, by University of East London psychologist John Read, a prominent critic of psychiatric drugs, found that 72% of respondents reported withdrawal effects such as insomnia, nausea and anxiety, and half of those called them severe. About 18% described psychotic symptoms. The respondents volunteered and were not clinically examined. One finding stands without qualification: not one of the 585 recalled being warned about withdrawal when the drug was prescribed.

The Alternative to Meds Center had warned them, Carina said: almost everyone who tapers below 1.5 mg needs inpatient help, and many do end up in a hospital. This is a great suggestion, but this should be the standard of care, maybe even the law Carina believes. David Pedersen reached that point and went past it. His psychiatrist put in writing that he needed an emergency room or acute care. His wife asked deputies, a hospital, the courts and the sheriff to get him there. He was never admitted.

Loading Viewer…


The Taper and the Trap

The Pedersen’s tried to do it right.

In early 2025 they began a slow taper, she said, guided by the Alternative to Meds Center, an Arizona clinic they reached mostly by hotline. They tapered every 12 weeks and brought him from 12 mg to 1.5 mg in about a year, she said.

He came back to himself as the dose fell, she said. He joined the welding program, worked double days and cared for her and the animals while she was pregnant. “From 12 down to 1.5, his personality was loving, kind, caring himself,” she told investigators. They kept a calendar. They made rules: David could not drive. He would never change a dose without her.

When they reached 1.5 mg, his doctor prescribed a 1.5 mg pill so they would not have to split tablets. The clinic said the next step required liquid risperidone, which can be measured in drops. They agreed to hold where they were until they found a doctor in Elko to prescribe it.

Then life came all at once. Their son arrived March 7th, 2026, a month early, unable to hold his body temperature. Elko’s hospital has no newborn intensive care unit; the nearest was three hours away. They were moving, half packed, with a fragile baby.

On April 11, about a month after his last planned taper, David came out of the bathroom and told her he had tried to only take half of his pill.

“I instantly saw it affect him,” she said. “It was like almost instant psychosis.”

The taper immediately affected David’s judgement and desicion making skills. Within weeks he had stopped Invega entirely. By her calendar, June 23 marked four weeks without it. His hallucinations were like NEVER before.

He stopped eating. He stopped drinking water. He believed people were poisoning him, and then he believed it was her. He disappeared for 18 hours at a stretch with no phone and no money, and wrecked his truck. The last time she saw him before he vanished, he ran out the door slashing at demons in the air. He was unable to finish his welding program that he loved.

David’s perception of reality had worsened. Once he smeared his own blood on a door and told her it was “the blood of the lamb,” because he was “the lamb”.

After he came home from Hawaii there was a window of two days. She got him to eat and take magnesium. He cried, prayed with her and let her care for him. She had found a facility in Utah that would take him. Then he bought a weight-loss product at a local health store, she said, and took it. “It was like a light switch,” she said.

A Warning on Official Letterhead

By late May, his own psychiatrist was alarmed.

On May 27, David’s doctor wrote a letter “To whom it may concern.” David had been under his care since August 2021, it says. “Based on the information that has been provided it appears that he is in a relapsed state of his condition and the alleged behaviors of his are noted to be a danger to himself and others,” the doctor wrote. He called for “immediate evaluation and intervention” at an emergency room, or acute care.

A doctor called it relapse. Other, well published psychiatrists such as Horowitz, Murray, and Phelps, called it a rebound effect or physical withdrawal. His wife calls it withdrawal. The research says the two can be near impossible to tell apart. What matters here is that the man who prescribed the drug put in writing that David Pedersen was dangerous and needed immediate help.

She took that letter to the Elko County Sheriff’s Office.

The Door Marked Sheriff

The deputies already knew. One morning, she said, Deputy Valdez called her around 7 a.m. to say her husband sounded “out of his mind.” David had phoned the station himself, claiming people were poisoning him with a rag, and he was bringing the rag in.

Weeks later, she called Valdez and asked him to meet her at the law office to photograph the psychiatrist’s note and David’s prescription bottle. She was there with her baby. When he arrived, she said, they met outside. He wore what she called a smug look. Then, she said, he yelled at her without warning. He told her “your husband’s just trying to divorce you,” took no pictures, did nothing and walked away.

The deputy who had heard for himself that David sounded out of his mind would not photograph the doctor’s note that said so.

When David went missing due to the mental health crisis, she kept calling due to the grave danger to her family. A deputy told her she was harassing them, she said.

Idaho authorities told her Nevada had to enter David as a missing and endangered person so any agency that found him could hold him for help, she said. She tracked him to Hawaii; police there said the same. She called Northeastern Nevada Regional Hospital to ask how to get him admitted. When she named the drug he had stopped, she said, the woman on the line gasped: “Why aren’t the sheriffs helping you?”

She tried the courts. Paralegals told her David would have to sign. David was missing.

So on June 2 she went to the top. With her infant son in her arms and David’s family friend, beside her, she sat in front of Sheriff Aitor Narvaiza, the elected head of the department. A deputy named Boatman was in the room, she said. The sheriff read the doctors letter, she said, acknowledged the danger and told Boatman to start the paperwork to enter David as missing and endangered.

David’s family friend left to care for his horses. The sheriff left. She stayed, alone with the baby, filling out forms.

Then Lt. Douglas Fisher walked in.

He had never spoken to her, she said. He had never seen the letter. “I’m not taking away this guy’s rights,” he said, by her account. “You guys are just getting a divorce.” He told her she knew where David was. She didn’t.

Fisher stopped the paperwork for the hold, she said, and with it the family’s best chance of getting David to a hospital.

The next day, Carina and her family friends went back to the sheriff’s office to confront the decision. There, she said, Sheriff Narvaiza told her family friend that Carina was lying and that her David was only trying to get away from her. When she pressed him, she said, Narvaiza told her Fisher “knows the law.” She could not understand how she could be called a liar, she said, and her faith that the law would protect her family was gone.

While David was still missing, she said, she asked Fisher whether the family simply had to wait for something terrible to happen for David to hurt himself or someone else.

“Yes, unfortunately, that’s what has to happen,” Fisher told her, by her account. “Law enforcement is reactive, not proactive.”

She repeated that remark to sheriff’s investigators four days after the attack, in a recorded interview, and said she had told the sheriff, too.

Consider what the department had on June 2: a wife, a best friend, a psychiatrist’s letter, a missing man, police in two other states asking for the entry. Consider who decided. Not the sheriff, by her account, who had already said yes. A lieutenant who walked in after he left.

Law Enforcement Is Reactive, Not Proactive

David came home worse.

Between June 2 and Aug. 10, deputies came to the house about 10 times, she estimates, most often because David called them himself. He reported people in the attic and the garage; deputies climbed up to look. Terrified of his wife, he called for welfare checks on the baby. On one visit, she said, she asked why there were no notes on the house after so many calls. A young deputy apologized and said he would add one.

Each visit, by her account, started from zero.

About a week and a half before the attack, David called deputies and told them his wife was someone else, a girl named Emily, and a witch. “He said she’s a witch,” she said. He had cut himself and smeared blood on the walls. The deputies saw it, she said, and told her it was getting dangerous.

She asked for a Legal 2000.

Under Nevada law, an officer may take a person in a mental health crisis into custody for emergency evaluation. It is the tool built for this moment: a man in psychosis, a documented danger, a family begging.

The two deputies looked at each other, she said. Then they told her to go to court and get a restraining order. “We’re not doctors,” deputies kept telling her, she said.

“So you want me to put my family member who’s having a medical crisis out into the streets with nowhere to go?” she asks now. “That’s your solution?”

The hospital, with its psychiatric unit, sits 9.3 miles from the house. “If the officer said, ‘David, you’re having psychosis symptoms that are dangerous to your wife and yourself. We gotta go get you checked. Come with us to the hospital,'” she said, “he would have gone.”

The deputies left. “Body cam footage is going to show it all,” she said.

After she came home from the hospital and finished her interview with investigators, a local paramedic captain, a friend of a friend, came to check on her, she said. He told her that if she had lived inside Elko city limits, where the Elko Police Department handles such calls, officers would have placed her husband on a Legal 2000 hold, she said.

In early August, on a day she remembers as 106 degrees, David put gasoline in his diesel truck, locked himself out without his phone, keys or wallet, and walked about 14 miles home. He came in burned red, filthy and near collapse, and shut himself in his room with a jug of water.

On Aug. 10 he told her someone was changing the words in his Bible. He asked whether she saw the people standing in the room. She didn’t. He said he was throwing the Bible away.

That evening she played worship music softly while she washed dishes. One of David’s own songs came on. “This is daddy’s song,” she told the baby.

An hour later, the tragedy.

The Terrible Night

Bleeding, vomiting, blood filling her eyes, she grabbed the baby and her phone and locked herself in the dark bathroom. The screen was too slick with blood to dial until she wiped it. She lay in the tub and called 911 and texted a friend to come for her son. He was soaked in her blood. She does not think he saw the attack, and David never went toward him, she told investigators.

Deputies were dispatched just before 9:30 p.m., the sheriff’s office said, and forced their way in. They identified David as the aggressor “through prior contacts,” the department said the same contacts she had been begging them to act on. He barricaded himself in a bedroom and, after commands from SWAT, “eventually willingly came out of the house and was arrested without further incident.”

Trapped inside the dark, her screams echoed off the cold tile of the bathroom, a harrowing, lonely siren before anyone finally arrived. When help did come, a female deputy took the baby, leaving her to drag her broken body to the ambulance entirely alone.

At the hospital, Carina’s friend stood waiting in the shadows. Then came Boatman, fresh off a promotion to detective, her nightmare assigned as his very first case.


“Is this Hawaii girl?” he asked.

Trapped in a gurney, prepared to be life-flighted, she looked him in the eye. “This could have been prevented.”

She was flown to Salt Lake City, where surgeons began working on her eye before she was under, she said, and she felt them cut. Her injuries: lacerations to both eyelids; staples in her scalp; a broken thumb; a broken orbital bone; a retinal tear; a choroidal rupture at the center of the eye, which she describes as a broken television screen; a destroyed tear duct system, now held open by a stent; an eye that sits an inch lower than it should; a concussion and symptoms of brain injury. She will need monitoring for bleeding behind the eye for life. Until her good eye adapts, which could take more than a year, she can see only with the injured one patched. In a letter to the sheriff’s office she wrote that she lost the vision in her left eye and also suffered a fractured jaw.

The pain of losing my eyesight and all of the pain does not compare to losing my family,” she said. “It would almost be easier if my husband died. I can mourn him. He’s not dead.”

The Price of an Unanswered Call

Irony clung to the iron bars: the very system that failed David before the bloodshed now locked him away tight.

For two long months, he languished in the Elko County Jail, starved of the psychiatric help he desperately needed, until a judge finally ruled him incompetent to stand trial. Bound for Lakes Crossing Center, Nevada’s high-security forensic psychiatric hospital in Sparks, his mind was slated for “restoration.” Twice, she had written to his keepers there, a desperate ultimatum echoing into a void: Do not put him back on Invega, or anything in its family.

A statement by Carina, with the weight of a shattered life in every syllable, is being declared. Yet, even though the trauma and the terror, the agonizing paradox remains: “My husband is a victim too.”

That statement matters. Domestic violence experts know a familiar pattern: a victim who defends her attacker after years of control and isolation. Her account does not follow it. She says David had never laid a hand on her before; “he was my safe person,” she told investigators. She was not cut off from help. She went looking for it, from his psychiatrist, a tapering clinic, the courts, police in three states and the sheriff himself. She kept her career, her friends and her church. She does not deny the attack. She blames what she believes caused it.

She had the interview transcribed and sent it to the prosecutor after he told her he did not have time to watch it. David’s public defender will not speak with her, the victim. A private defense attorney would cost $100,000; she has been told.

At a hearing on her protective order, she said, she told the judge that law enforcement had failed her husband. The judge told her it was not law enforcement’s job. When she tried to answer with Nevada’s Legal 2000 law, which gives officers the power to take a person in a mental health crisis to a hospital, the judge ended the exchange, she said.

She is left with questions. If it is not law enforcement’s job, why does the law give officers that power? And why did police in Idaho and Hawaii say David qualified as missing and endangered, based on his diagnosis alone, when deputies at home would not?

She lost her job weeks after returning from medical leave. She lives alone with her son, now 7 months old, and the horses and chickens. She fears losing the house.

On Sept. 11 she sent the sheriff’s office a demand to preserve evidence, with notice that she intends to sue under the federal civil rights law known as Section 1983. She sent it again Sept. 22, to Boatman, Kaber, another county employee and the sheriff. The letter, which she provided to the Post, demands the department keep every 911 call, body camera recording and draft of the “Legal 2000 materials … including any documents prepared, partially prepared, or abandoned,” along with the personnel and disciplinary files of “the lieutenant who declined to proceed.” The department answered through its lawyer, she said.

She and others are preparing a product-liability claim against J&J.

A Time to Mourn

Carina Pedersen is grieving a husband who is still alive. “It would almost be easier if my husband died,” she said. “I can mourn him.”

She does not pretend the attack did not happen. She prays for David every day, and she has spent every week since August fighting for him. It is the love the old vows promise, in sickness and in health, and the love Paul described: it “beareth all things, believeth all things, hopeth all things, endureth all things.” A testament that God can overcome the industries of the earth.

“To every thing there is a season,” the preacher wrote, “a time to mourn.” This is hers. She is mourning her husband, her sight and the life they built, and she is fighting anyway.

What Must Change

The federal government should pull Invega from the market immediately. Johnson & Johnson should pull it first. It will not.

Until then, the FDA should act in the national interest and order emergency tapering and withdrawal guidance onto the Invega label, and require the same of every antipsychotic sold in the United States.

Prescribers should write the last step of a taper before they write the first, with a crisis plan the family holds.

The Elko County Sheriff’s Office should submit the June 2 decision and the Legal 2000 refusal to independent review, adopt a written emergency-hold policy, require notes on repeat calls to a house and train every deputy in crisis intervention.

Nevada lawmakers should let a spouse petition for an emergency hold without the missing patient’s signature.

And the jail and the state should treat a man in psychosis within days, not months, and answer his wife’s letters.

None of it will happen because it is right. It will happen when enough people put it on the record.

What You Can Do

Help Carina Pedersen. Pedersen is raising money through her GoFundMe, “Healing from Tragedy and Fighting for Justice.” She organized the campaign herself. It covers medical bills and upcoming surgeries, keeping a roof over her and her son’s heads, childcare and help at home while she heals, rides to appointments four hours away and lawyer fees for her civil case and a planned case against the drug’s manufacturer. She lost her job weeks after the attack, and her savings are gone, she wrote. Donations to personal GoFundMe campaigns generally are not tax-deductible. “If you can’t give, please pray for us,” she wrote. “Every share will help.”

Report the drug. If Invega, Invega Sustenna or any antipsychotic hurt someone you love, whether starting it, changing the dose or stopping, file a MedWatch report with the FDA at fda.gov/medwatch or 1-800-FDA-1088. You do not need to be a doctor, and you do not need proof the drug caused it. The FDA counts what it is told. What no one reports, it never sees. You can also report directly to Janssen, the drug’s maker, at 1-800-526-7736.

Call your members of Congress. The Capitol switchboard, 202-224-3121, connects to any senator or representative. Ask one question: Why does the Invega label tell doctors how to start the drug and nothing about how to stop it?

Call your state legislators. Nevadans can find theirs at leg.state.nv.us and Oklahomans at oklegislature.gov. Ask for emergency-hold laws that let a spouse or parent get help for someone in crisis, even when that person is missing.

Vote. Elko County chooses a sheriff on Nov. 3. Ask every candidate what he or she will do with the next Legal 2000 call.

Tell us. If this happened to your family, write to editor@theokpost.com. We will not publish your name or story without your permission.

“There’s gotta be a reason why I survived,” Carina Pedersen said.

The verse she holds to now is Philippians 4:13: “I can do all things through Christ which strengtheneth me.”


Carina Pedersen is raising money for medical bills, upcoming surgeries, childcare, rides to appointments four hours away and legal costs through her GoFundMe page,

“Healing from Tragedy and Fighting for Justice.”

If you cannot give, she asks that you pray for her family and share the page.

Has This Happened to Your Family?

The Oklahoma Post is collecting accounts from families whose loved ones had a crisis while starting, changing or stopping Invega, Invega Sustenna or another antipsychotic. Write to editor@theokpost.com. We will not publish your name or story without your permission.

Before changing any psychiatric medication, talk to the prescribing doctor. Stopping some medicines suddenly can be dangerous. To report a bad reaction, file a MedWatch report with the FDA at 1-800-FDA-1088.

If you or someone you know is in crisis, call or text 988.

Writing By: Robbie Robertson | Editing by Gregory Moyer


EDITOR’S NOTE: Not the First Family

Editor’s note: This section concerns my son. I’m the editor and publisher of The Oklahoma Post. Carina Pedersen found us through my earlier coverage of my son’s case.

When Carina told me her story, I recognized every turn of it.

My son, Peyton Moyer, is serving life in prison in Georgia. Just after midnight on Dec. 28, 2021, he shot and killed his mother, Ashley Schutza, 41, and her partner, Benjamin Smith, 54, at their home near Watkinsville, Oconee County deputies said. His sisters, 16 and 4, were in the house and were not physically hurt. He was 20. In November 2023 he pleaded guilty and was sentenced to life.

None of the media coverage of Peyton’s case mentioned Invega. Nobody mentioned his first abuser, Burt Shutza. Nobody mentioned the abuse of his ADHD medication by himself and his family. Nobody mentioned the neglect and provisions of drugs and alcohol to a minor. Nobody mentioned the gun in the home. Nobody mentioned the parental alienation.

At 14 or 15, on a family trip, Peyton was given methamphetamine by his uncle, Ray MacElroy, I later learned, and had a psychotic break. No one called me. No one called the police. Doctors put him on Invega.

For years, the legal battles raged across state and federal dockets, a father’s desperate crusade to pull his children out of harm’s way, shouting warnings into a system that turned a deaf ear to the abuse waiting at home. In 2021, a brief sanctuary appeared. Peyton came to Oklahoma, finding refuge with his father, where they set to work building a future through helping Peyton obtain his GED and a drivers license.

Then, the gavel fell again. A court order tore him away, casting him back across state lines to Georgia, back into the home that broke him, and forcing the chemical grip of Invega Sustenna back into his veins by judicial mandate.

The drug’s own label says its “safety and effectiveness” in patients under 18 “have not been established.” In juvenile animal studies described on the label, young rats on paliperidone showed impaired learning and memory, and young dogs given risperidone, which the body turns into paliperidone, showed shorter, less dense bones and delayed sexual maturation. The drug’s long-term effects on growth and sexual maturation, the label says, “have not been fully evaluated in children and adolescents.”

Then came the same descent. He called to tell me he had watched me die in a plane crash. He asked if his grandmother was alive because he had seen her death on TV. He cut himself and left blood everywhere. I called the crisis lines and the sheriff’s office. I begged them to make sure there were no guns in that house.

About a week later, my son killed his mother and her partner, the two people that abused him.

Two families. Two states. Two men coming on or off the same drug, two trails of blood on the walls, two sets of warnings to the people with badges. Both times, the warnings were called warnings only after the violence.

The question has reached a more famous house. Rob and Michele Singer Reiner were killed in Los Angeles in December 2025, and their son Nick is charged with their murders. TMZ, citing unnamed sources, reported that his schizophrenia medication had been switched a month before. No drug has been publicly named.

“The difference with my case is I’m not the one considered insane,” Carina told me. “No one believes those people, and the other survivors are dead or in prison.”


Sources

The charges and court: Elko Daily Free Press

The Aug. 10 call, arrest and prior contacts, per the sheriff’s office: KUTV and ABC News, Nadine El-Bawab, Aug. 12, 2026

Invega tablets, dosing and administration: FDA-approved prescribing information, 2021

Invega Sustenna approval and use: Johnson & Johnson

Antipsychotic tapering research: Horowitz et al., Schizophrenia Bulletin, 2021, reviewed by Psychopharmacology Institute

Antipsychotic withdrawal and relapse: RADAR trial, The Lancet Psychiatry, 2023; pooled analysis of 1,388 patients, 2024; Viguera et al., Archives of General Psychiatry, 1997; Read, Addictive Behaviors Reports, 2022

The PRIDE study and jail marketing: Johnson & Johnson press release, Jan. 3, 2018; The Marshall Project, Taylor Elizabeth Eldridge, Feb. 14, 2018; The Oklahoma Post, “The Stay-Out-of-Jail Shot”

Peyton Moyer’s treatment: The Oklahoma Post, “How Invega Sustenna’s Marketing Turned Courts into Pill Mills,” Dec. 21, 2025

Splitting Invega tablets: J&J Medical Connect

Antipsychotics and violent crime: Fazel et al., The Lancet, 2014

Substance-induced psychosis and schizophrenia: Murrie et al., Schizophrenia Bulletin, 2020; Niemi-Pynttäri et al., Journal of Clinical Psychiatry, 2013; Starzer et al., American Journal of Psychiatry, 2018; Kendler et al., American Journal of Psychiatry, 2019; Wearne and Cornish, Frontiers in Psychiatry, 2018; methamphetamine psychosis duration, Frontiers in Human Neuroscience, 2014

Schizophrenia overdiagnosis: Johns Hopkins Medicine

Discontinuation and mortality: Tiihonen et al., American Journal of Psychiatry, 2018

The 2013 settlement: CBS News and Drug Topics

Nevada emergency mental health holds: NRS 433A.160

Elko County Sheriff’s Office personnel: Nevada State Emergency Response Commission, Elko County LEPC roster, 2026

Peyton Moyer’s case: Oxygen, WSB-TV and WUGA

The Reiner case: KTVU

Invega Sustenna label: https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/INVEGA+SUSTENNA-pi.pdf.

or

https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022264s037lbledt.pdf

Bible.com: https://www.bible.com/bible/1/PHP.4.13

Tapering services: TaperClinic https://taperclinic.com Families looking for help with tapering have few places to turn. TaperClinic, is a virtual service whose website says its psychiatrists work only on helping patients taper psychiatric medications, with individual plans and regular monitoring. The Oklahoma Post does not endorse any clinic and has no financial relationship with either. Speak with your doctor. Then speak with more if needed.

Carina Pedersen’s account: interviews with The Oklahoma Post, Oct. 19 and Oct. 22, 2026; her Oct. 13 letter to Lakes Crossing Center; and Dr. Narendra Reddy’s May 27 letter, which she provided


© 2026 The Oklahoma Post | By The People’s Popular Paper


2026 — The Oklahoma Post — TheOKPost.com is dedicated to delivering relevant news and information to Oklahomans and to sharing their stories, pictures, and experiences. Content on this website includes fact-checked, verified-source reporting created by The Oklahoma Post, as well as contributions from various individuals and links to external public and privately owned sources. The views and opinions expressed in user-generated content are solely those of the respective authors and do not necessarily reflect those of The Oklahoma Post. The Oklahoma Post does not independently verify the accuracy of third-party contributions and relies upon contributors to fact-check their work. By sharing links and allowing open contributions, TheOKPost.com exercises its right to free speech and provides a platform for diverse perspectives.